The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories, L.P. Dr. Feldman is a consultant and speaker for Galderma, Connetics, Abbott Labs, Warner Chilcott, Centocor, Amgen, Photomedix, Genentech, Biogenidec, and Bristol Myers Squib; has received grants from Galderma, Connetics, Astellas, Abbott Labs, Warner Chilcott, Centocor, Amgen, Photomedix, Genentech, Biogenidec, Coria, Pharmaderm, Dermatology Foundation, American Society of Dermatologic Surgery, National Psoriasis Foundation, Ortho Pharmaceuticals, Aventis Pharmaceuticals, Roche Dermatology, 3M, Bristol Myers Squibb, Stiefel, GlaxoSmithKline, and Novartis; and has received stock options from Photomedix. Dr. Dabade, Dr. Williford, Mr. Davis and Ms. Ahn have no conflicts to disclose.
Cosmetic Procedures Performed in the United States: A 16-Year Analysis
Article first published online: 18 JUL 2013
© 2013 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.
Volume 39, Issue 9, pages 1351–1359, September 2013
How to Cite
Ahn, C. S., Davis, S. A., Dabade, T. S., Williford, P. M. and Feldman, S. R. (2013), Cosmetic Procedures Performed in the United States: A 16-Year Analysis. Dermatologic Surgery, 39: 1351–1359. doi: 10.1111/dsu.12267
- Issue published online: 3 SEP 2013
- Article first published online: 18 JUL 2013
Cosmetic procedures, particularly those that are minimally invasive, are in demand. The physician specialties performing these procedures are not well-characterized.
To examine changes in the frequency of cosmetic dermatologic procedures performed in the United States from 1995 to 2010 and the physician specialties performing them.
The volume of cosmetic procedures performed by physician specialties and the types of cosmetic procedures performed were determined from data from the National Ambulatory Medical Care Survey (NAMCS) from 1995 to 2010.
Cosmetic procedures constituted 8.7% of all skin procedures and have increased since 1995 (p < .001). Botulinum toxin injections were the most frequently performed cosmetic procedure and increased at the greatest rate over time. Plastic surgeons performed the largest proportion of cosmetic procedures (36.1%), followed by dermatologists (33.7%), but other specialties have been performing an increasing proportion of cosmetic procedures. This study was limited to the provision of outpatient procedures, and the nationally representative data of the NAMCS is subject to sample bias.
Plastic surgeons and other physicians performed the majority of outpatient cosmetic procedures. Dermatologists performed one-third of ambulatory cosmetic procedures from 1995 to 2010. This broadening spectrum of physicians and nonphysicians providing cosmetic procedures may have important implications for patient safety.